Snowball logo
logo
23I

Intra-Cellular Therapies Inc

122.000.00  (0%)
Start your journey to financial independence
Snowball will help you to track your portfolio, plan deposits to your brokerage account and increase passive income
Start

Frequently Asked Questions

What sector does Intra-Cellular Therapies Inc (23I) operate in?

Intra-Cellular Therapies Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Intra-Cellular Therapies Inc (23I) current stock price?

What is Intra-Cellular Therapies Inc (23I) current market capitalization?

Intra-Cellular Therapies Inc market cap is approximately 13.00 billion.

What is Intra-Cellular Therapies Inc (23I) Earnings Per Share (EPS)?

The trailing EPS is -€0.67.

Does Intra-Cellular Therapies Inc (23I) dividends?

No. Intra-Cellular Therapies Inc does not pay a dividend.

When is Intra-Cellular Therapies Inc (23I) next earnings report?

Intra-Cellular Therapies Inc is expected to release its next earnings report on March 31, 2025.